| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/14/2009 | US20090124534 Trehalose Click Polymers for Delivery of Biologically Active Molecules |
| 05/14/2009 | US20090123938 Contacting a candidate antagonist with a MCP-1 receptor polypeptide having an amino acid sequence at least 95% homologous to an extracellular domain of a specific sequence, and comparing the binding of MCP-1 to the receptor polypeptide; decreased binding indicates an antagonist |
| 05/14/2009 | US20090123936 Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 05/14/2009 | US20090123573 Admixture of extracts of plants of the genus rosmarinus and carotenoids for treating cutaneous symptoms of aging |
| 05/14/2009 | US20090123568 Kit useful for treating tumors and lesions of the skin and the mucous membranes |
| 05/14/2009 | US20090123530 Liposome Drug Delivery |
| 05/14/2009 | US20090123509 Biodegradable Colloidal Gels as Moldable Tissue Engineering Scaffolds |
| 05/14/2009 | US20090123458 having a modified histidine residue with a fluorine at the 2-position so that the pKa of the modified histidine residue is less than about 3; vaccine for the treatment of anthrax |
| 05/14/2009 | US20090123451 Slow intraventricular delivery |
| 05/14/2009 | US20090123448 Nucleic acid molecules coding for a dextransaccharase catalysing the synthesis of dextran with alpha 1,2 osidic sidechains |
| 05/14/2009 | US20090123379 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor |
| 05/14/2009 | US20090123377 Method for Testing Substances or Mixtures of Substances,Use of Said Method and Corresponding Test Kits |
| 05/14/2009 | US20090123370 Alphavbeta6 peptide ligands and their uses |
| 05/14/2009 | DE60226044T2 Kristalline formen von fluvastatin-natrium Crystalline form of fluvastatin sodium |
| 05/14/2009 | DE10163130B4 Apoptotisch wirksame Peptide und diese umfassende pharmazeutische Zusammensetzungen Apoptotic active peptides and pharmaceutical compositions comprising |
| 05/14/2009 | CA2705303A1 Modulation of protein trafficking |
| 05/14/2009 | CA2703987A1 Cyclobutyl carboxylic acid derivatives |
| 05/13/2009 | EP2058658A2 Method and means for influencing intercellular communication and intercellular organelle transport |
| 05/13/2009 | EP2058333A2 Anti-CCR2 antibodies and methods of use therefor |
| 05/13/2009 | EP2058310A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor comprising the derivative |
| 05/13/2009 | EP2058305A1 Urea derivative |
| 05/13/2009 | EP2058304A1 P2x4 receptor antagonist |
| 05/13/2009 | EP2058302A1 Method for producing phenoxypyridine derivative |
| 05/13/2009 | EP2058009A1 Reverse targeting lipid vesicle |
| 05/13/2009 | EP2058008A1 Anti-obesity agent and use thereof |
| 05/13/2009 | EP2057997A1 Preventive and/or therapeutic agent for peripheral neuropathy |
| 05/13/2009 | EP2057905A1 Composition for moderating Triglyceride and Cholesterol Levels |
| 05/13/2009 | EP2056872A2 Influenza hemagglutinin and neuraminidase variants |
| 05/13/2009 | EP2056808A2 Small molecule potentiator of hormonal therapy for breast cancer |
| 05/13/2009 | EP2056803A2 Thiol-based agents for reducing toxicities associated with medical procedures employing radiographic contrast agents |
| 05/13/2009 | EP1721610B1 Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 05/13/2009 | EP1655028B1 Use of cyclic bioisosteres of purine system derivatives for the treatment of diseases caused by disorders of nitrergic and dopaminergic systems |
| 05/13/2009 | EP1515972B1 Amide substituted xanthine derivatives with gluconeogenesis modulating activity |
| 05/13/2009 | EP1485477B1 Novel type-1 cytokine receptor glm-r |
| 05/13/2009 | EP1478778B1 Method and nucleic acids for the analysis of a colon cell proliferactive disorder |
| 05/13/2009 | EP1397356B1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 05/13/2009 | EP1355646B1 Muscarinic receptor agonists |
| 05/13/2009 | EP1320540B1 Peptidomimetic protease inhibitors |
| 05/13/2009 | EP1309692B1 Anti-il-12 antibodies, compositions, methods and uses |
| 05/13/2009 | EP1305026B1 Barbituric acid analogs as therapeutic agents |
| 05/13/2009 | EP1299104B1 Tamper-resistant oral opioid agonist formulations |
| 05/13/2009 | EP1220617B1 Fish feed with increased nucleotide content |
| 05/13/2009 | EP1212405B1 Use of cytokines, cells, and mitogens to inhibit graft versus host disease |
| 05/13/2009 | EP1062209B1 Metabolically inert anti-inflammatory and anti-tumor antifolates |
| 05/13/2009 | CN101432295A Peptide |
| 05/13/2009 | CN101432284A Dihydropyrazolopyrimidinone derivative |
| 05/13/2009 | CN101432280A Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
| 05/13/2009 | CN101429151A IDO restrainer containing (E)-4-(beta-bromo vinyl)benzoyloxy structure |
| 05/13/2009 | CN101428134A Process for producing four-Tibet inula root soft capsule |
| 05/13/2009 | CN101428105A Method of preparing medicine for quickly resolving stagnation |
| 05/13/2009 | CN101428100A Method of preparing power for treating Jiuguerxiao |
| 05/13/2009 | CN101428076A Process for producing cassia twig tuckahoe formulation |
| 05/13/2009 | CN101428001A Preparation of O/W type medium chain fatty acid microemulsion |
| 05/13/2009 | CN100486996C Antibodies to human MCP-1 |
| 05/13/2009 | CN100486992C Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiongenesis |
| 05/13/2009 | CN100486969C Cis-2,4,5-triphenyl-imidazoline and its application in tumor treatment |
| 05/13/2009 | CN100486967C 5HT2C receptor modulators |
| 05/13/2009 | CN100486634C Medicine for treating organ cyst and its preparing method |
| 05/13/2009 | CN100486623C Tablet for clearing spirit, nourishing brain, tonifying blood and qi, quieting spirit, boosting intelligence, improving hearing and vision, and production method thereof |
| 05/13/2009 | CN100486576C Substituted pyridinones as modulators of P38MAP kinase |
| 05/13/2009 | CN100486574C Remedies and/or preventives for nervous system disorders |
| 05/13/2009 | CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use |
| 05/13/2009 | CN100486570C Use of luciferin and derivatives in preparing medicine for treating live animal secretory diarrhea and inhibiting cyst growth |
| 05/13/2009 | CN100486562C Medicine composition for treating coronary heart disease and its preparation process and use |
| 05/13/2009 | CN100486464C Preparation method of sweet potato health beverage |
| 05/12/2009 | US7531676 Bipolar; cationic head linked to a hydrophobic backbone and a hydrophilic tail; capable of self assembly to form stable complexes in aqueous solutions; use for the delivery of bioactive substances such as nucleic acids to cells in vitro and especially in vivo |
| 05/12/2009 | US7531636 A proinflammatory cytokine; monoclonal antibodies, or mixture of polyclonal antibodies; blocks signal transduction; hematopoietic cell proliferation |
| 05/12/2009 | US7531621 Of the formula, [Cha7,11, des-Met8, Nle18, Tyr34]hPTH(1-34)NH2; disorders of the central nervous system, metabolism, pancreas, and hypothalmus; irregular blood pressure, male infertility; agonists or antagonists |
| 05/12/2009 | US7531576 N-alkyl-N-(p-substituted-phenyl)benzylamine that is N-substituted with carbocyclic aminocarbonylalkylene, aminocarbonyl, or aminocarbonylaminosulfonyl; ACAT inhibitors; treating e.g.,hypercholesterolemia and atherosclerosis |
| 05/12/2009 | US7531573 Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease |
| 05/12/2009 | US7531567 effector ambroxole with ACE inhibitors; treatment of a disturbance of the thiol-disulfide status in kidney replacement therapy |
| 05/12/2009 | US7531549 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 05/12/2009 | US7531544 Xanthine phosphodiesterase V inhibitors |
| 05/12/2009 | US7531540 phosphodiesterase type 4 inhibitors; to treat respiratory disorders, skin disorders like psoriasis and atopic eczema; low toxicity, high bioavailability, no significant side effects; 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-acetamide |
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/12/2009 | US7531532 Pyridine derivative and pyrimidine derivative |
| 05/12/2009 | US7531531 Method of treating diseases associated with altered kinase activity with bicyclo-pyrazoles |
| 05/12/2009 | US7531526 Boronic ester and acid compounds, synthesis and uses |
| 05/12/2009 | US7531516 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
| 05/12/2009 | US7531511 Injecting fibroblast growth factor-2 directly into the myocardium |
| 05/12/2009 | US7531510 Methods of recruiting fibroblasts by administering G-CSF |
| 05/12/2009 | US7531504 Peptide antagonists of zonulin that bind to the zonula occludens receptor, yet do not physiologically modulate the opening of mammalian tight junctions; tablets, capsules |
| 05/12/2009 | US7531499 Spermine to facilitate absorption of cilostazol, rebamipide, cyclosporin and nifedipine |
| 05/12/2009 | US7531304 Method for screening FGFR-4 agonists |
| 05/12/2009 | US7531171 Antibodies to non-functional P2X7 receptor |
| 05/12/2009 | CA2492526C Method for controlling hairballs |
| 05/12/2009 | CA2419178C Cytokine production inhibitor |
| 05/12/2009 | CA2377301C Controlled release and taste masking oral pharmaceutical compositions |
| 05/12/2009 | CA2335353C Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ards) and infant respiratory distress syndrome (irds) |
| 05/12/2009 | CA2334875C Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome |
| 05/12/2009 | CA2322027C Use of macrolide compounds for the treatment of ards |
| 05/12/2009 | CA2315829C Angiostatic agents and compositions for controlling ocular hypertension |
| 05/12/2009 | CA2264005C Piperazino derivatives as neurokinin antagonists |
| 05/12/2009 | CA2228266C Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs |
| 05/12/2009 | CA2201940C Method of treating diabetes mellitus using kgf |
| 05/07/2009 | WO2009058394A1 Cytidine analogs for treatment of myelodysplastic syndromes |
| 05/07/2009 | WO2009058238A1 Substituted diazepan orexin receptor antagonists |
| 05/07/2009 | WO2009057790A1 Medicine and medical instrument containing osteogenic and chondrogenic protein |
| 05/07/2009 | WO2009057775A1 Anti-fatigue agent comprising amino acid composition |
| 05/07/2009 | WO2009057743A1 Antiallergic drink containing lactic acid bacterium |